Argentina's National Program for Control of Breast Cancer: Time 1, Patient Navigation, and Patient Cancer Education Experience

J Cancer Educ. 2022 Dec;37(6):1669-1676. doi: 10.1007/s13187-021-02011-4. Epub 2021 Apr 27.

Abstract

Argentina has the second highest mortality rate for breast cancer (BC) in South America. The age-standardized incidence of BC in Argentina is 73 per 100,000. Despite the availability of early detection services, 30% of BCs are diagnosed at advanced disease stages. The National Cancer Institute (NCI) of Argentina and the National Program for Control of Breast Cancer (NPCBC) focus on two main objectives: guaranteeing adequate and timely BC treatment and reducing BC mortality in Argentina. These objectives are addressed by maintaining three core concepts: quality control, disease monitoring, and wide coverage of available early detection and treatment services. The NPCBC is currently implementing the "Time 1 Survey Study." Time 1 is defined as the time from the first appearance of BC signs or symptoms to the first consult within the public healthcare system. This timeframe is important in Argentina because it is outside of the health timeframes and data parameters monitored by the national cancer data registry system. The Time 1 Survey study has the potential to serve as an informational tool for BC patient navigation efforts in Argentina because it can be used to identify and characterize the barriers and delays that women face during Time 1. Lessons and experiences included in this study could be translated to other Latin American and middle-income countries for developing cancer control programs that can lead to improving treatment and reducing mortality through patient navigation and cancer education efforts for the public, health professionals, and patients.

Keywords: Argentina; Barriers; Breast cancer; Cancer education; Latin America; Patient navigation; Time 1.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Argentina / epidemiology
  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / prevention & control
  • Female
  • Humans
  • Incidence
  • Income
  • Patient Navigation*